newsfilter
← Latest News
GlobeNewswire·

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • On May 1, 2026, Praxis Precision Medicines granted restricted stock unit awards covering 5,420 common shares to twenty-one new non-executive employees.
  • The grants were issued under the 2024 Inducement Plan as material inducements for employment in compliance with Nasdaq Listing Rule 5635(c)(4).
  • The 2024 Inducement Plan is used exclusively for equity awards to individuals who were not previously employed by Praxis or returned after a bona fide non-employment period.
  • The restricted stock units will vest in four equal annual installments, contingent upon continued employment on each vesting date.